你即將離開本站

並前往https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma_pas.cfm?t_id=347267&c_id=555

Post-Approval Studies (PAS) Database - Accessdata.fda.gov

Date Current Protocol Accepted, 04/22/2011. Study Name, Stelkast Surpass Active PAS. General Study Protocol Parameters. Study Design, Active Surveillance.

確定！ 回上一頁

查詢 「SURPASS study」的人也找了：

  1. SURPASS study
    2.
  2. Tirzepatide
    3.
  3. SURPASS-3 tirzepatide
    4.
  4. SURPASS 4 tirzepatide
    5.
  5. Tirzepatide lancet
    6.
  6. Tirzepatide a potential new agent for type 2 diabetes
    7.
  7. SURPASS-CVOT
    8.
  8. Tirzepatide FDA
    9.